References
- Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268–75.
- Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1 – a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001;142:1371–6.
- Smith RE, Li KX, Andrews RK, Krozowski Z. Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology 1997;138:540–7.
- Farman N, Rafestin-Oblin ME. Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 2001;280:F181–92.
- Kimura RS, Schuknecht H. Membranous hydrops in the inner ear of guinea pig after obliteration of the endolymphatic sac. Pract Otorhinolaryngol (Basel) 1965;27:343–54.
- Furuta H, Sato C, Kawaguchi Y, Miyashita T, Mori N. Expression of mRNAs encoding hormone receptors in the endolymphatic sac of the rat. Acta Otolaryngol 1999;119:53–7.
- Mori N, Yura K, Uozumi N, Sakai S. Effect of aldosterone antagonist on the DC potential in the endolymphatic sac. Ann Otol Rhinol Laryngol 1991;100:72–5.
- ten Cate WJ, Zuo J, Lautermann J, Altenhoff P, Rarey KE. Development of 11 beta-hydroxysteroid dehydrogenase expression in the rat cochlea. Acta Otolaryngol 1997;117:841–4.
- Akiyama K, Miyashita T, Matsubara A, Mori T, Inamoto R, Nishiyama A, A new approach for selective rat endolymphatic sac epithelium collection to obtain pure specific RNA. Biochem Biophys Res Commun 2008;376:611–14.
- Kim SW, de Seigneux S, Sassen MC, Lee J, Kim J, Knepper MA, Increased apical targeting of renal ENaC subunits and decreased expression of 11betaHSD2 in HgCl2-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 2006;290:F674–87.
- Dahlmann A, von During M. The endolymphatic duct and sac of the rat: a histological, ultrastructural, and immunocytochemical investigation. Cell Tissue Res 1995;282:277–89.
- Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol 2005;19:2211–21.
- Kumagami H, Loewenheim H, Beitz E, Wild K, Schwartz H, Yamashita K, The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch 1998;436:970–5.
- Waddell BJ, Hisheh S, Krozowski ZS, Burton PJ. Localization of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the male reproductive tract. Endocrinology 2003;144:3101–6.
- Shea JJ Jr, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am 1996;29:353–8.
- Turner BB. Tissue differences in the up-regulation of glucocorticoid-binding proteins in the rat. Endocrinology 1986;118:1211–16.
- Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 1996;115:38–41.
- Shimazaki T, Ichimiya I, Suzuki M, Mogi G. Localization of glucocorticoid receptors in the murine inner ear. Ann Otol Rhinol Laryngol 2002;111:1133–8.
- Komune S, Wakizono S, Nakagawa T, Kimituki T, Hisashi K, Uemura T. Ototoxic effect of potassium canrenoate on the guinea pig cochlea. Acta Otolaryngol 1991;111:719–27.
- Mori N, Uozumi N, Yura K, Sakai S. The difference in endocochlear and endolymphatic sac d.c. potentials in response to furosemide and canrenoate as diuretics. Eur Arch Otorhinolaryngol 1990;247:371–3.